1.
Pagani M, Bavbek S, Alvarez-Cuesta E, et al. Hypersensitivityreactions to chemotherapy: an EAACI position paper. Allergy.2022;77(2):388-403.
2.
Henwood JM, Brogden RN. Etoposide. A review of itspharmacodynamic and pharmacokinetic properties, andtherapeutic potential in combination chemotherapy of cancer.Drugs. 1990;39(3):438-490.
3.
Martinez N, Miyasaki A, Roh L, Koole W, Fernandez KS. Apediatric desensitization protocol for etoposide. Am J Health SystPharm. 2020;77(4):277-281.
4.
Wright TE, Shah MD, Rider NL, et al. A case series of pediatriconcology patients undergoing successful rapid etoposidedesensitization. Pediatr Allergy Immunol. 2019;30(5):579-582.
5.
Cotteret C, Rousseau J, Zribi K, Schlatter J. Severe hypersensitivityreaction to etoposide phosphate: a case report. Clin Case Rep.2020;8(9):1821-1823.
6.
Hoetelmans RM, Schornagel JH, ten Bokkel Huinink WW,Beijnen JH. Hypersensitivity reactions to etoposide. AnnPharmacother. 1996;30(4):367-371.
7.
Hudson MM, Weinstein HJ, Donaldson SS, et al. Acutehypersensitivity reactions to etoposide in a VEPA regimen forHodgkin’s disease. J Clin Oncol. 1993;11(6):1080-1084.
8.
Bernstein BJ, Troner MB. Successful rechallenge with etoposidephosphate after an acute hypersensitivity reaction to etoposide.Pharmacotherapy. 1999;19(8):989-991.
9.
Siderov J, Prasad P, De Boer R, Desai J. Safe administrationof etoposide phosphate after hypersensitivity reaction tointravenous etoposide. Br J Cancer. 2002;86(1):12-13.
10.
Lindsay H, Gaynon P. Anaphylactic reaction to etoposidephosphate. Pediatr Blood Cancer. 2012;59(4):765.
11.
Ogle KM, Kennedy BJ. Hypersensitivity reactions to etoposide.A case report and review of the literature. Am J Clin Oncol.1988;11(6):663-665.
12.
Vervloet D, Durham S. Adverse reactions to drugs. BMJ.1998;316(7143):1511-1514.
13.
Zweizig S, Roman LD, Muderspach LI. Death from anaphylaxisto cisplatin: a case report. Gynecol Oncol. 1994;53(1):121-122.
14.
Castells M, Sancho-Serra Mdel C, Simarro M. Hypersensitivityto antineoplastic agents: mechanisms and treatment with rapiddesensitization. Cancer Immunol Immunother. 2012;61(9):1575-1584.
15.
Buhari GK, Kalkan IK, Ates H, et al. Platin desensitizationsin thoracic malignancies and risk factors for breakthroughreactions. Allergol Immunopathol (Madr). 2023;51(2):130-136.
16.
Demoly P, Adkinson NF, Brockow K, et al. Internationalconsensus on drug allergy. Allergy. 2014;69(4):420-437.
17.
Brown SG. Clinical features and severity grading of anaphylaxis.J Allergy Clin Immunol. 2004;114(2):371-376.
18.
Castells MC, Tennant NM, Sloane DE, et al. Hypersensitivityreactions to chemotherapy: outcomes and safety of rapiddesensitization in 413 cases. J Allergy Clin Immunol.2008;122(3):574-580.
19.
Stockton WM, Nguyen T, Zhang L, Dowling TC. Etoposide andetoposide phosphate hypersensitivity in children: incidence,risk factors, and prevention strategies. J Oncol Pharm Pract.2020;26(2):397-405.
20.
Turgay Yagmur I, Guzelkucuk Z, Yarali N, et al. Evaluationof hypersensitivity reactions to cancer chemotherapeuticagents in pediatric patients. Ann Allergy Asthma Immunol.2020;124(4):350-366.
21.
Picard M. Management of hypersensitivity reactions to taxanes.Immunol Allergy Clin North Am. 2017;37(4):679-693.
22.
Friedland D, Gorman G, Treat J. Hypersensitivity reactions fromtaxol and etoposide. J Natl Cancer Inst. 1993;85(24):2036.
23.
Leguay Z, Bourneau-Martin D, Pellier I, et al. Successful treatmentwith etoposide base after an acute hypersensitivity reaction toetoposide phosphate. Pediatr Blood Cancer. 2016;63(3):571.
24.
Collier K, Schink C, Young AM, How K, Seckl M, Savage P.Successful treatment with etoposide phosphate in patientswith previous etoposide hypersensitivity. J Oncol Pharm Pract.2008;14(1):51-55.
25.
Sambasivan K, Mahmoud S, Kokache A, Seckl M, Savage P.Hypersensitivity reactions to etoposide phosphate. J OncolPharm Pract. 2014;20(2):158-160.
26.
Babaie D, Shamsian BS, Momtazmanesh N, et al. Rapiddesensitization for hypersensitivity reactions to chemotherapeuticdrugs; a case series. Iran J Pharm Res. 2019;18(2):1047-1051.
27.
Pantin C, Letellez J, Calzas J, Mohedano E. [Indirect identificationof hypersensitivity reaction to etoposide mediated by polysorbate80]. Farm Hosp. 2018;42(1):27-28.
28.
Kellie SJ, Crist WM, Pui CH, et al. Hypersensitivity reactionsto epipodophyllotoxins in children with acute lymphoblasticleukemia. Cancer. 1991;67(4):1070-1075.
29.
Kulhas Celik I, Guvenir H, Buyuktiryaki B, Dibek Misirlioglu E,Ozyoruk D, Toyran M. Successful desensitization to etoposidein a preschool pediatric patient. J Investig Allergol Clin Immunol.2018;28(5):363-364.
30.
Garcia Escallon S, Muniyappa PK, Subramanian S. Successfulrapid desensitization to intravenous etoposide using a 14-stepprotocol. J Allergy Clin Immunol Pract. 2015;3(4):627-628.